Pharmaceuticals FDA Committee Votes Against Approval of Lycos Therapeutics’ MDMA Drug for PTSD Last updated: June 5, 2024 6:41 pm By bexib 0 Min Read Share SHARE In a majority decision, the Advisory Committee on Mental Drugs cited concerns about the data presented on MDMA as a treatment for post-traumatic stress disorder. You Might Also Like APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins New ways to determine drug value with health equity in mind Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer Share This Article Facebook Twitter Email Print Previous Article How To Sell Food Online: Step-by-Step Startup Guide (2024) Next Article US corn harvest strong, but funds pressure market prices – RealAgriculture Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay ConnectedFacebookLikeTwitterFollowYoutubeSubscribeTelegramFollowLatest News Schedule for the week of November 10, 2024 Economy Link November 9, 2024 | Naked Capitalism Economy Many voters support abortion rights and Donald Trump as a challenge to Democrats Economy Northcote Obsession celebrates 25th anniversary with an exciting line-up of chefs to deliver the best in hospitality Hospitality & Tourism